![](/img/cover-not-exists.png)
First in human trial of the poly(ADP)-ribose polymerase inhibitor MK-4827 in patients with advanced cancer with antitumor activity in BRCA-deficient and sporadic ovarian cancers
R. Wenham, G. Wilding, R. Baird, L. Sun, C. Toniatti, M. Stroh, C. Carpenter, J. de-Bono, S. Sandhu, W. SchelmanVolume:
120
Year:
2011
Language:
english
Pages:
1
DOI:
10.1016/j.ygyno.2010.12.015
File:
PDF, 71 KB
english, 2011